Allergan (AGN) Income Statement

Click line-items for a historical chart and %

Product net sales	1.79B
Other revenues	26.4M
Total revenues	1.82B
Cost of sales (excludes amortization of acquired intangible assets)	206.6M
Selling, general and administrative	714.7M
Research and development	288.5M
Amortization of acquired intangible assets
Intangible asset impairment and related costs
Restructuring charges	185.5M
Operating income	392.8M
Interest income	2M
Interest expense	-18.4M
Other, net	43M
Total non-operating income (expense)	26.6M
Earnings before income taxes	419.4M
Provision for income taxes	106.3M
Net earnings	313.4M
Net earnings attributable to noncontrolling interest	900K
Net earnings attributable to Allergan, Inc.	312.5M
Basic (in dollars per share)	1.05
Diluted (in dollars per share)	1.03

Entities mentioned with AGN

View All Entities